- Home
- ZURA vs NAUT Comparison
ZURA vs NAUT Comparison
Compare ZURA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZURA | NAUT |
|---|---|---|
| Founded | 2022 | 2016 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 383.5M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZURA | NAUT |
|---|---|---|
| Price | $5.93 | $3.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $11.78 | $4.00 |
| AVG Volume (30 Days) | ★ 475.6K | 325.1K |
| Earning Date | 03-19-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.62 |
| 52 Week High | $7.25 | $4.31 |
Technical Indicators
Market Signals| Indicator | ZURA | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 63.04 |
| Support Level | $5.62 | $1.93 |
| Resistance Level | $6.99 | N/A |
| Average True Range (ATR) | 0.49 | 0.35 |
| MACD | -0.09 | 0.11 |
| Stochastic Oscillator | 34.16 | 59.28 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.